Purchase Order 75N93020P00498

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $186.4 million delivery order to PPD Development LP for NIAID Clinical Site Monitoring (NCSM) services. This delivery order, which carries a cost-plus fixed fee pricing structure with no set-aside designation, is scheduled for completion by January 31, 2031, and will be performed in Cape Fear, North Carolina. PPD Development LP, a global contract research organization and subsidiary of Thermo Fisher Scientific,...

The National Institute of Allergy and Infectious Diseases awarded a $1.86 million cost-plus-fixed-fee task order (75N93022F00001) to PPD Development LP for administration and overall clinical operations support and concept development under the Early Phase Clinical Trial Units (EPCTU) indefinite delivery/indefinite quantity contract. The task order, issued on January 14, 2022, with an ultimate completion date of January 13, 2032, represents the base award for clinical trial management and...

This is a $34,618,531.80 cost-plus-fixed-fee delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to PPD Development LP, a global contract research organization. The task order is to provide comprehensive clinical trial management support services for the ongoing ACTIV-2 clinical trial related to COVID-19 research. It is part of NIAID's "Comprehensive and Rapid Response for NIAID Research Programs" contract vehicle, a $545 million multiple-award...

This is a federal contract award to PPD Development LP, a global contract research organization and subsidiary of Thermo Fisher Scientific, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services. The contract, valued at $139,861,060.22, is for NIAID Clinical Site Monitoring services. This is a definitive contract with a cost-plus-fixed-fee pricing type, with a period of performance through January 31, 2024. The...

This is a $5,758,524.34 delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to PPD Development LP, a global contract research organization (CRO). The contract is to provide monitoring services for a Phase III clinical trial, specifically trial A5300B/PHOENIX. It is a cost-plus-fixed-fee contract with an ultimate completion date of December 14, 2025. The contract was awarded on April 15, 2019 and is not...

The National Institute of Allergy and Infectious Diseases issued a delivery order to Advanced Bioscience Laboratories, Inc., on September 6, 2017, with a ceiling value of $110,115.92 under the Preclinical Services for Biopharmaceutical Product Development IDIQ. Place of performance is Rockville, MD. The order was initially set to run through February 10, 2018 and was extended to April 13, 2018 at no additional cost. Pricing is cost plus fixed fee. No set-aside was used for this order.

This is a $27,437,094.36 cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to PPD Development LP, a global contract research organization (CRO) and subsidiary of Thermo Fisher Scientific. The contract is for research and development (R&D) in the biomedical (basic research) domain, specifically in support of NIAID's Regulatory Management Center. The contract does not have a set-aside designation and was awarded on a...

PPD Development LP was awarded a $2 million delivery order against the National Institutes of Health's Comprehensive and Rapid Response for NIAID Research Programs contract vehicle to provide research support services to the National Institute of Allergy and Infectious Diseases. The firm-fixed price order, taking place in Bethesda, Maryland, runs from September 2021 through August 2022 and will support NIAID's mission through the delivery of comprehensive and rapid response capabilities for...

The National Institute of Allergy and Infectious Diseases awarded a $36.4 million definitive contract to PPD Development LP for clinical site monitoring center services on June 30, 2022, under cost-plus-fixed-fee pricing with performance completion by June 29, 2027. The originating pre-solicitation (posted August 31, 2020) sought clinical site monitoring capability for NIAID-funded clinical research programs, with the contract structured as a single-award vehicle covering one base year and six...

This is a Cost Plus Fixed Fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to PPD Development LP, a global contract research organization (CRO). The contract, valued at $66,339,562.95, is for the TAS::75 0885::TAS NIAID DAIT CLINICAL SITE MONITORING CENTER and has a performance period ending on February 23, 2023. PPD Development LP, a subsidiary of Thermo Fisher...